NASDAQ: INCYIncyte Corp Stock Ownership - Who owns Incyte?
Insider buying vs selling
Have Incyte Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sheila A. Denton | EVP General Counsel | 2025-10-15 | 277 | $85.13 | $23.58kSell |
| Sheila A. Denton | EVP General Counsel | 2025-10-15 | 277 | $64.25 | $17.80kBuy |
| Sheila A. Denton | EVP General Counsel | 2025-10-03 | 3,501 | $85.54 | $299.48kSell |
| Sheila A. Denton | EVP General Counsel | 2025-10-02 | 599 | $58.06 | $34.78kBuy |
| Sheila A. Denton | EVP General Counsel | 2025-10-02 | 3,130 | $86.28 | $270.06kSell |
| Sheila A. Denton | EVP General Counsel | 2025-10-02 | 599 | $87.65 | $52.50kSell |
| Lee Heeson | EVP Head of Incyte Intl | 2025-10-01 | 463 | $86.70 | $40.14kSell |
| Patrick A. Mayes | EVP Chief Scientific Officer | 2025-10-01 | 1,569 | $86.70 | $136.03kSell |
| Edmund Harrigan | Director | 2025-09-30 | 289 | $84.81 | $24.51kBuy |
| Paul J. Clancy | Director | 2025-09-30 | 285 | $84.81 | $24.17kBuy |
INCY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when INCY insiders and whales buy or sell their stock.
INCY Shareholders
What type of owners hold Incyte Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Baker Bros Advisors LP | 15.66% | 30,743,275 | $2.87B | Institution |
| Vanguard Group Inc | 10.26% | 20,135,393 | $1.88B | Institution |
| Julian Baker | 10.11% | 19,851,744 | $1.86B | Insider |
| Blackrock Inc | 9.15% | 17,956,808 | $1.68B | Institution |
| Dodge Cox | 7.43% | 14,595,181 | $1.36B | Institution |
| Baker Brothers Life Sciences LP | 6.34% | 12,445,783 | $1.16B | Insider |
| Baker Brothers Life Sciences Capital GP LLC | 6.33% | 12,430,783 | $1.16B | Insider |
| State Street Corp | 5.03% | 9,875,758 | $923.19M | Institution |
| Aqr Capital Management LLC | 4.18% | 8,201,455 | $766.67M | Institution |
| Baker Biotech Capital GP LLC | 2.50% | 4,911,003 | $459.08M | Insider |
INCY vs Biotech Stocks
Incyte Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.